About Avidea

We are developing safer and more effective immunotherapies through innovations in polymer-drug conjugate (PDC) technologies.

Our scientific team

Our technology and team are building on more than two decades of pioneering work by our world-class scientific founders and advisors from the National Institutes of Health, the University of Oxford, the Institute for Macromolecular Chemistry and Johns Hopkins. Our founders, advisors and collaborators are experts in the fields of immunology, oncology, vaccines and materials science. We apply the interdisciplinary expertise of our team to overcome key challenges in drug delivery and advance promising immunotherapies from concept through development.


Scientific advisory board and advisors

Key collaborators